Dexcom G7 CGM System
Simple. Accurate.†,1 Effective.
The most accurate CGM System available to Canadians †,1, clinically proven to lower A1C for people living with Type 1 and Type 2 diabetes.2-7
No routine finger pricks* or scanning
Make routine fingersticks a thing of the past.* Real-time monitoring of your glucose levels, day and night.
Glucose readings in real time
Make smarter decisions with confidence about insulin, food and activity in the moment, to take better control of your diabetes.
Alerts before you’re low
Dexcom G7 can predict when you’re going low so you can take action to prevent it.
All-in-one wearable
The smallest CGM1 that’s easy-to-use and painless to apply.1,8
Dexcom G7 Continuous Glucose Monitoring (CGM) System is for everyone with Type 1 or Type 2 diabetes using insulin.
Using Dexcom CGM with an integrated insulin pump system?
Click here to learn more about your options.
Click here to learn more about your options.
How do I purchase Dexcom G7?
Dexcom G7 is exclusively available at your local pharmacy.
If you currently have a prescription and coverage for Dexcom G6, please consult with your doctor if switching to Dexcom G7 is right for you. Click the link below for insurance coverage updates by province or insurance plan.
Dexcom G7 Patient Benefit Program
Canadians living with diabetes can get up to 20% off the out-of-pocket cost* of Dexcom G7 sensors at pharmacy
The Dexcom G7 Patient Benefit Program assists in reducing or sometimes even eliminating out-of-pocket costs for people living with diabetes who use the Dexcom G7 CGM System, making it more affordable than ever!
Download a copy of the program certificate below which can be redeemed at any pharmacy and should be presented with a valid Dexcom G7 prescription.
Explore Dexcom G7
Are you new to CGM?
Learn how Dexcom CGM and how it can give you the confidence to live life to the fullest.
† When compared with CGM systems commercially available in Canada as of October 2023.
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1 Dexcom, data on file, 2023.
2 Beck, RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7 Heinemann L, et al. Lancet 2018;391 :1367-77.
8 Patients reported 94% of insertions were painless (mild, no pain).
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1 Dexcom, data on file, 2023.
2 Beck, RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7 Heinemann L, et al. Lancet 2018;391 :1367-77.
8 Patients reported 94% of insertions were painless (mild, no pain).